Skip to main content
. 2025 Jun 26;13(7):690. doi: 10.3390/vaccines13070690
AIDS Acquired Immunodeficiency Syndrome
Alum Aluminum hydroxide gel adjuvant
ALVAC Canarypox virus vector
Ad26/Ad5 Adenovirus serotype 26/5 vectors
bnAb Broadly neutralizing antibody
Env Envelope
eOD-GT8 Engineered Outer Domain-Germline Targeting 8
Gag Group-specific antigen
gp120 Glycoprotein 120
HIV Human immunodeficiency virus
HVTN HIV Vaccine Trials Network
IAVI International AIDS Vaccine Initiative
LNP Lipid nanoparticle
MF59 Oil-in-water emulsion adjuvant
MSM Men who have sex with men
Nef Negative factor
Pol Polymerase
PrEP Pre-exposure prophylaxis
VRC01 Vaccine Research Center 01 antibody (specific bnAb)